User profiles for "author:Michael Baum"

Michael J. Baum

Emeritus Professor of Biology, Boston University
Verified email at bu.edu
Cited by 13916

Differentiation of coital behavior in mammals: a comparative analysis

MJ Baum - Neuroscience & Biobehavioral Reviews, 1979 - Elsevier
The evidence reviewed suggests that in all mammalian species the adult male's ability to
display masculine coital behavior depends in part on exposure of the developing brain to …

Diversity maintenance and use of Vicia faba L. genetic resources

G Duc, S Bao, M Baum, B Redden, M Sadiki… - Field Crops …, 2010 - Elsevier
The faba bean (Vicia faba L.) is an ancient crop that is represented in collections by
cultivated forms only. Botanic and molecular data suggest that the wild ancestor of this …

Neuroendocrine regulation of GnRH release in induced ovulators

J Bakker, MJ Baum - Frontiers in neuroendocrinology, 2000 - Elsevier
GnRH is the key neuropeptide controlling reproductive function in all vertebrate species.
Two different neuroendocrine mechanisms have evolved among female mammals to …

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett… - Lancet, 2005 - thelancet.com
The standard adjuvant endocrine treatment for postmenopausal women with hormone-
receptor-positive localised breast cancer is 5 years of tamoxifen, but recurrences and side …

[PDF][PDF] Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen

M Dowsett, J Cuzick, J Ingle, A Coates… - Journal of Clinical …, 2010 - academia.edu
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus
Tamoxifen Page 1 Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase …

[HTML][HTML] Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from …

JS Vaidya, F Wenz, M Bulsara, JS Tobias, DJ Joseph… - The Lancet, 2014 - thelancet.com
Summary Background The TARGIT-A trial compared risk-adapted radiotherapy using single-
dose targeted intraoperative radiotherapy (TARGIT) versus fractionated external beam …

[HTML][HTML] Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non …

JS Vaidya, DJ Joseph, JS Tobias, M Bulsara, F Wenz… - The Lancet, 2010 - thelancet.com
Background After breast-conserving surgery, 90% of local recurrences occur within the
index quadrant despite the presence of multicentric cancers elsewhere in the breast. Thus …

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

J Cuzick, I Sestak, M Baum, A Buzdar, A Howell… - The lancet …, 2010 - thelancet.com
Summary Background The Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial was
designed to compare the efficacy and safety of anastrozole (1 mg) with tamoxifen (20 mg) …

Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.

LJ Fallowfield, A Hall, GP Maguire, M Baum - British medical journal, 1990 - bmj.com
OBJECTIVES--To assess outside a clinical trial the psychological outcome of different
treatment policies in women with early breast cancer who underwent either mastectomy or …

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy.

J Cuzick, H Stewart, L Rutqvist, J Houghton… - Journal of Clinical …, 1994 - ascopubs.org
PURPOSE To examine long-term cause-specific mortality in patients irradiated for breast
cancer as part of a randomized clinical trial. PATIENTS AND METHODS We studied all …